Converting Problems into Opportunities When Building Up a Biobank

Pharma IQ

Pharma IQ is joined by Mark Divers, Executive Director, KI Biobank at Karolinska Institute, to discuss some of the prevalent aspects in the growing field of biobanking, from international partnerships to standardising protocol. [inlinead]
To continue reading this story get free access